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Abstract
Objectives: Assessment factors (AFs) are commonly used for deriving reference concentrations for chemicals. These fac-
tors take into account variabilities as well as uncertainties in the dataset, such as inter-species and intra-species variabilities 
or exposure duration extrapolation or extrapolation from the lowest-observed-adverse-effect level (LOAEL) to the no-
observed-adverse-effect level (NOAEL). In a deterministic approach, the value of an AF is the result of a debate among 
experts and, often a conservative value is used as a default choice. A probabilistic framework to better take into account 
uncertainties and/or variability when setting occupational exposure limits (OELs) is presented and discussed in this paper. 
Material and Methods: Each AF is considered as a random variable with a probabilistic distribution. A short literature was 
conducted before setting default distributions ranges and shapes for each AF commonly used. A random sampling, using 
Monte Carlo techniques, is then used for propagating the identified uncertainties and computing the final OEL distribu-
tion. Results: Starting from the broad default distributions obtained, experts narrow it to its most likely range, according to 
the scientific knowledge available for a specific chemical. Introducing distribution rather than single deterministic values 
allows disclosing and clarifying variability and/or uncertainties inherent to the OEL construction process. Conclusions: 
This probabilistic approach yields quantitative insight into both the possible range and the relative likelihood of values 
for model outputs. It thereby provides a better support in decision-making and improves transparency. Int J Occup Med 
Environ Health 2018;31(4)
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INTRODUCTION
Since 2005 the French Agency for Food, Environmental 
and Occupational Health and Safety (ANSES) has been 
responsible for organizing an independent, multidisci-
plinary, collective scientific expertise for setting occupa-
tional exposure limits (OELs). A dedicated independent 
expert committee (OEL Committee) has been set up to 
support the Agency in this mission.
The French system for establishing regulatory OELs is or-
ganized following 3 phases:
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variability. AFs may also be applied to take into account 
differences in exposure conditions between laboratory 
studies and actual worker exposure or uncertainties around 
the POD (LOAEL vs. NOAEL, for example). These factors 
may thus be broken down into inter-species, intra-species, 
time-related and data-related uncertainty assessment fac-
tors. The values of these factors are often sources of contro-
versy and debate and so it is necessary to ensure that their 
choice is justified, transparent and not unduly influenced by 
risk management considerations.
It is generally assumed that AFs are values that fall within 
intervals of 1–10 for inter-species variability and 1–5 for 
variability in the population of healthy adults. The choice 
of an appropriate value for the AF is usually discussed by 
experts, based on the available data for the substance con-
sidered. Several limitations of the deterministic approach 
must be pointed out:
 – A point estimate of a value does not adequately reflect 
variability and uncertainty around this value. If there is 
no specific or conclusive data, the experts will usually 
choose a prudent default value, thus often considering 
a “worst-case” situation.
 – The multiplication of prudent assessment factors may 
result in an overestimated overall factor and therefore 
unrealistic reference values.
In order to better take into account uncertainties and/or 
variability in the process of OELs elaboration, it was de-
cided to develop an ad hoc probabilistic approach [3]. The 
probabilistic approach intends to describe more clearly 
variability and/or uncertainties in yielding quantitative 
insight into both the possible range and the relative likeli-
hood of values for model outputs.
A probabilistic approach, using Monte Carlo (MC) simu-
lation, to establish OELs is investigated in this study. Its 
possible uses and limitations are discussed. This approach 
only covers substances for which a threshold effect may be 
assumed. Substances without a threshold (e.g., genotoxic 
carcinogens) have not been considered in this study.
 – independent scientific expertise by the OEL Commit-
tee leading to recommendations of occupational expo-
sure limits for chemical agents; this is the only phase 
entrusted to the Agency;
 – publication by the French Ministry of Labour of a draft 
regulation document which includes proposals for new 
limit values, which may be binding or indicative;
 – stakeholders consultation on these proposals and discus-
sion among the French Steering Committee on Working 
Conditions (COCT). The aim of this phase is to discuss 
the effectiveness of the limit values and, if necessary, to 
determine a possible implementation timetable, accord-
ing to its technical and economic feasibility.
Occupational exposure limits, as proposed by the OEL 
Committee, are concentration levels of pollutants in the 
workplace atmospheres that should not be exceeded over 
a determined reference period and below which the risk of 
impaired health is considered negligible [1]. These concen-
tration levels are established considering a population of 
workers, thus excluding both the children and the elderly.
Occupational exposure limits are determined based on 
information available from epidemiological, clinical and 
experimental studies. The establishment of OELs as for 
other reference values such as toxicity reference val-
ues (TRVs) or indoor air quality guidelines (IAQGs) usu-
ally relies on a deterministic approach [2]. This approach 
produces a single point estimate of the OEL by dividing 
the point of departure (POD), which may be the no-
observed-adverse-effect level (NOAEL), the lowest-
observed-adverse-effect level (LOAEL) or a benchmark 
dose (BMD) by the product of assessment factors (AFs).
Assessment factors applied to the POD are expected to off-
set variability and uncertainties related to the data taken 
into account and their interpretation in the adjustment pro-
cess. Assessment factors may reflect uncertainties related 
to the lack of knowledge (e.g., uncertainty related to the ex-
tent to which an effect observed in the case of animals may 
be transposed to humans) as well as intra or inter-individual 
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ease Registry (ATSDR) reports, for gases/liquids, in 62% 
of the cases, humans seemed to be more sensitive than ani-
mals. This percentage drops to 53% in the case of particles. 
Possible distributions for AFA were investigated through 
several studies in comparing animal–animal NOAEL ra-
tios or animal–human NOAEL ratios. Vermeire et al. 
analyzed mouse, rat and dog data and found out that 
the NOAELs ratios were lognormally distributed. When 
adjusted for allometric scaling, their distribution had a geo-
metric mean (GM) of about 1 and a geometric standard 
deviation (GSD) of 6 [6]. The author suggested that the 
large GSD observed was due to the variability of the NO-
AEL itself and that the true inter-species distribution was 
probably smaller. This argument was supported by results 
from the previous study, reporting the GSD of about 5 [7] 
as well as a further analysis and extension of Vermeire’s 
data, which lead to the GSD of 4.5 [8]. Moreover, several 
authors proposed theoretical distributions consistent with 
the current worst case default factor of 10 [9,10].
More recently Schneider et al. [11] has compared toxi-
cological data on 63 anti-neoplastic agents among 6 spe-
cies. When adjusted by scaling according to the caloric 
demand, the inter-species ratios distributions were found 
to be similar and approximating 1. The GM and GSD of 
the resulting empirical distribution were 0.97 and 3.23, 
respectively (95th percentile = 7.04). A higher variabil-
ity was observed by Price when analyzing anti-neoplastic 
data issued from the National Cancer Institute. Inter-
species ratios above 10 were found in about 20% of the 
data points. These ratios were, however, possibly overes-
timated because the data was obtained from a sensitive 
subpopulation of cancer patients [12].
Inter-individual factor
The inter-individual assessment factor (AFH) takes into 
account variations in the population such as age, gender, 
genetics composition and nutrition. The use of specific 
data to assess the appropriate inter-individual variability is 
MATERIAL AND METHODS
Uncertainties and ranges of existing assessment factors
The determination of likely ranges and probability distri-
bution for each assessment factor requires a high level of 
scientific expertise. The information that is needed can-
not be obtained directly from reference material. Expert 
judgment is therefore used but should be supported by 
assumptions, publications and/or other data sources. Fur-
thermore, when different distributions are possible for 
a given AF, the sensitivity analysis should be conducted in 
order to weight the different options [4]. A review of the 
literature was carried out, for each usual source of uncer-
tainty, i.e., each AF, in the OEL context (i.e., exposure to 
chemical by inhalation during occupational activities), in 
order to define what might be their extreme values, the 
shape of their distributions among theoretical probability 
law (uniform, triangular, log-normal, etc.) and the associ-
ated parameters of these distributions (e.g., mean, stan-
dard deviation, percentiles). The available empirical data 
published is not always relevant to chemical substances 
found in occupational environments. The dataset used in 
this study to elaborate the AF’s distributions has therefore 
been critically analyzed taking into account the context 
of the OELs’ development.
Inter-species assessment factor
An inter-species assessment factor (AFA) is necessary 
when extrapolating from animal data to human data. 
Adjustment through the AFA allows for the estimation 
of a human equivalent dose (HED), taking into account 
toxicokinetic and toxicodynamic differences between spe-
cies. The AFA is frequently divided into 2 subfactors: an 
allometric assessment factor, which takes into account dif-
ferences induced by body size and related differences in 
metabolic rate, and species-specific differences.
In the study from Kalberlah et al. [5] on respiratory toxi-
cants, it has been shown that when comparing LOAELs 
and NOAELs from 33 Agency for Toxic Substances and Dis-
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based on the data from acute toxicity and heterogeneity 
amongst rats. The distribution of the GM = 2.7 and the 
GSD = 2.3 was obtained assuming an identical heteroge-
neity in the case of rats and humans, while the distribu-
tion of the GM = 5.3 and the GSD = 2.1 was obtained 
assuming that humans were 1.5 times more heteroge-
neous than rats [7]. Swartout et al. proposed the distri-
bution of the GM = 3.16 and the 95th percentile of 10, 
arguing that 3.16 was close to the frequently used de-
fault value of 3 and that 10 corresponded to the upper 
default range [10]. Slob and Pieters proposed the distri-
bution of the GM = 4 and the 1st–99th percentile range 
of 2–10 [9]. This corresponds to the lognormal distribution 
with the median of 3 and the dispersion factor of 3 shifted 
by 1 unit on the right. It was assumed by the authors that 
the inter-species factor could not be smaller than one.
LOAEL to NOAEL extrapolation factor
Benchmark dose is considered to be the best indicator 
to be used as the POD to derive OELs. However, in the 
absence of benchmark doses, the NOAEL is generally 
considered to be the relevant point of departure to set 
an OEL. When no reliable NOAEL is available, experts 
have to start from the lowest-observed-adverse-effect 
level (LOAEL) and apply an assessment factor (AFL) to 
take into account the LOAEL/NOAEL ratio.
The default value of 3–10 for the AFL is frequently 
used, although limited data is available to support it. 
The LOAEL/NOAEL ratios of about 350 substances in-
cluding volatile organic compounds (VOCs), alcohols 
and pesticides were investigated by Pieters et al. [17]. 
The distribution of the data suggested a lognormal dis-
tribution of the LOAEL/NOAEL ratio. The geomet-
ric means of subacute (N = 95), subchronic (N = 226) 
and chronic (N = 175) LOAEL/NOAEL ratios found 
were 3.5, 4.3 and 4.5, respectively. The 95th percentiles 
found were of 9, 16 and 11, respectively. It was shown 
that, although an AFL of 10 is in the order of magnitude of
advocated whenever possible. Default values for the AFH 
in the general population, ranging between 3 and 10, 
have still been proposed by several national and interna-
tional organizations. While arbitrary, the historical value 
of 10 (upper default value) has subsided nowadays. The 
evidence to support a different value is currently lacking 
and it is generally considered that this value should be suf-
ficient to protect the majority of the population against 
adverse health effects [5,13].
Studies have been conducted to substitute or substantiate 
the existing default factors. Only a few of them are based on 
experimental data and the ones available are mostly based 
on pharmaceuticals substances rather than on industrial tox-
icants [14]. Hattis et al. investigated the total change in the 
pharmacokinetics of 49 drugs in the case of healthy adults 
and concluded that, except for one drug, the use of a safety 
factor 10 would correspond to 7–9 standard deviations in 
populations of normal healthy adults, suggesting that the 
tenfold factor was too conservative [15]. The further analy-
sis of these results showed that the inter-individual ratios, 
defined as the ratios of P50 and P5 plasma half-life-time dis-
tributions, were about 1.4 [6]. Considering the 5% incidence 
level in a given population, Hattis et al. assessed the effect 
of a tenfold decrease in exposure. The resulting incidences 
found were of 10–3–10–4, depending on the substance [16].
Although several studies suggest that the factor of 10 is 
sufficient to take into account pharmacokinetic variabil-
ity, the AFH could be underestimated. The available data 
was indeed obtained on healthy volunteers rather than 
a sensitive population and the pharmacodynamic effect is 
often insufficiently considered. After analyzing the avail-
able human data, Kalberlah et al. concluded that the fac-
tor of 10 may not be sufficient to cover sensitive popula-
tion under all circumstances [5].
Probability distributions of AFH were also proposed 
by several authors, either based on the data analysis or 
theoretical considerations. Most of them assume a log-
normal distribution. Baird et al. proposed distributions 
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periods) and that the GM value could be overestimated. 
He suggested that the GM of 2 and the GSD of 4, cor-
responding to a 95th percentile of 20, was a reasonable 
approximation. While it is generally agreed that the value 
of the predicted GM was within a narrow range, typical-
ly 1.5–2, there were few consensuses about the possible 
value of the GSD. Others authors suggested GSD values 
notably lower than the ones proposed by Vermeire et al. 
The GSD of 2.5 was suggested by Baird et al., who repeated 
the analysis of the part of the NOAEL available data [7]. 
Slob and Pieters argued that the AFS might have been 
overestimated because it was based on the NOAEL rather 
than on the “true” NAEL and thus contained additional 
uncertainty [9]. This argument was further investigated by 
Bokkers and Slob, who compared subchronic to chronic 
ratio using the NOAEL and critical effect doses [19]. The 
use of critical effect doses decrease significantly the distri-
bution GSD, leading to the 95th percentile 3.3 times lower 
and within the 2.9–3.3 range. It was concluded that AFs 
based on the NOAEL data may have lead to unnecessarily 
conservative values. Moreover, the 95th percentiles values 
observed by Bokkers and Slob were all below 10.
Studies investigating the subacute to subchronic assess-
ment factor are limited and tend to be based on smaller 
datasets than subchronic to chronic studies. Unsurprising-
ly, the variability of the observed distributions tends also 
to be higher. Vermeire et al. reported the default lognor-
mal distribution with the GM of 2 and the GSD of 4 [6]. 
Lower values were found by Groeneveld et al., who ob-
tained the lognormal distribution with the GM of 1.6 and 
the GSD of 3.3 [20]. With the 95th percentile of 11, this 
distribution is consistent with the default value of 10 for 
extrapolation from subacute to subchronic. A detailed in-
vestigation of rats and mouse NOAEL and the LOAEL 
data was conducted by Zarn et al. [18], who obtained 
distributions for subacute to subchronic ratios consistent 
with Groeneveld’s study. The ranges of the GM and GSD 
values observed were of 1.1–2.1 and 2.1–3.1, respectively.
the 95th percentiles observed, the value of 10 might have 
been even too low.
However, these results have to be considered carefully 
because the LOAEL/NOAEL ratio is strongly influenced 
by the study design [17]. One has to keep in mind that 
the no-observed-adverse-effect level (NOAEL) is only 
a proxy of the “true” no-adverse-effect level (NAEL), 
which will remain unknown. This uncertainty increases 
with the spacing between the NOAEL and the LOAEL, 
and thus the dose spacing of the study. Moreover, 
Zarn et al. highlighted that the dose spacing (and thus 
the LOAEL/NOAEL ratio within a same study) generally 
increased with exposure duration [18].
Exposure duration extrapolation factor
The extrapolation from subchronic to chronic studies has 
been investigated and published for several decades. In 
most cases, AFS was estimated using the NOAELsubchronic/
NOAELchronic ratio for the same species and critical effect. 
All authors concur with the assumption that the assess-
ment factor is lognormally distributed, mostly because of 
the lognormal behavior of the NOAEL data. The extent of 
its distribution is, however, still a matter of debate. Reviews 
of published studies on subchronic to chronic assessment 
factor were proposed by several authors. Pieters et al. re-
viewed the results from early studies reporting geometric 
means (GM) and geometric standard deviations (GSD) 
of 1.4–2.3 and 2.2–3, respectively [17]. Pieter’s own study, 
based on less homogenous data, resulted in a much wid-
er distribution (GM = 1.7; GSD = 5.6), suggesting that 
the default assessment factor of 10 could be too low.
The large variability of AFS was further highlighted by 
a thorough review conducted by Vermeire et al., which 
reported the GM and GSD ranges of 1–4.1 and 1.3–5.6, 
respectively (including the results already reported by Pi-
eters) [6]. Vermeire et al. pointed out that the observed 
variability might have been due to the heterogeneity of the 
data (inter-species variation, variable subchronic exposure 
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The first step of the probabilistic approach is to assign 
the probability distribution (probability density function) 
to each uncertain AF. These distributions may be derived 
from chemical-specific data, when available. In such a case, 
the GM represents the central estimate of the available data 
base of chemicals; while the GSD (width) is associated with 
the number of chemicals in the database, the methods to 
estimate the ratios/quantities that form the quantitative esti-
mate of the distribution as well as the specific characteristics 
of the chemical. In most cases, however, expert judgment is 
used for assessing the available toxicological data. In the first 
step, the maximum range of potential values relevant for 
each AF is specified. The probability distribution for the AF 
is then defined by selecting the shape (log-normal, uniform, 
triangular, etc.) and the associated parameters. In the sec-
ond step, the AFs’ probability distributions are propagated 
through the model [22]. As a general rule, these factors are as-
sumed to be independent. In practice, this is done to simulate 
separately an N random sampling of each uncertain AFs from 
their respective distribution. The model is then run repeat-
edly N times, supplied by the k sets of N simulated samples. 
Finally, a N-sample of the studied OEL is provided, from which 
one can retrieve the required statistics (mean, mode, stan-
dard deviation, percentiles, etc.), as described in the Figure 1.
Application to some case studies
For this study, the approach was applied to 2 selected 
substances: ethylene glycol monoethyl ether (EGEE) and 
ethylene glycol monoethyl ether acetate (EGEEA), for 
which the OELs committee had already proposed some 
deterministic OELs [3]. Three AFs were considered, the 
inter-species AF, the inter-individual AF and the exposure 
duration AF. For each of them, 100 000 random draws 
were performed using the R Statistical Software (ver-
sion 3.2). To compare both approaches, the AFs were ei-
ther deterministically determined or a priori distributed. 
The deterministic OEL was then compared to the distri-
bution of the OEL following the Monte Carlo approach.
Quality of data extrapolation factor
The assessment factor for quality of data, the AFD, ta-
kes into account the amount, quality, completeness 
and consistency of the available data. There is little 
argument to support a specific range or distribution 
for the AFD. Some authors suggested that the AFD 
could run up to 100 [6]. Although, it could be argued 
that when confidence in the data is so poor, it will un-
likely be used for deriving the OEL. Evans and Baird 
compared the NOAEL estimates for 35 pesticides de-
rived from censored and uncensored datasets [21]. 
A substantial increase in the precision of estimates was 
observed when the database became more complete. 
A wide dispersion of the estimated assessment factor, 
defined as the NOAEL-censored/NOAEL-uncensored 
ratio, was found. Database limitations, in terms of rep-
resentativeness and size, however precluded a strict 
probabilistic interpretation of these results.
Accounting for uncertainties 
in the OEL production process
Based on the literature screening and experience of the 
members of the French OEL committee, a probabilistic 
approach, making use of a classical Monte Carlo method, 
was developed. As shown in the equation 1, the probabi-
listic approach is based on the same model as the one used 
for setting OELs in a deterministic way. It is assumed, 
however, that some (if not all) of the AFs could be uncer-
tain or variable:
  

k
1i i
AF
POD
OEL
 (1)
where:
POD – chosen point of departure of OEL process (a NOAEL, 
LOAEL or a BMD),
k – number of assessment factors considered,
AFi – ith assessment factor for i = 1, …, k.
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AF – assessment factor; afk – assessment factor value for uncertainty k; POD – point of departure; i – ith value Monte Carlo simulation run; M – mean;  
SD – standard deviation.
Fig. 1. Propagation of numerical uncertainty using Monte Carlo methods through the process of occupational exposure  
limits (OELs) elaboration
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response relationship. A linear distribution (uniform) be-
tween 1 and 10 is chosen for the quality of data because 
no value is considered as more probable than the others 
within the uncertainty range. The default distribution for 
the AFA takes into account both toxicokinetic and toxico-
RESULTS
Distributions used to derive OEL
Considering the large uncertainties reported by the litera-
ture due to the lack of knowledge about the real variabil-
ity of most AFs, a pragmatic approach was chosen by the 
French OEL Committee [3]. An overview of its general 
framework is presented in the Figure 2. In this approach, 
the French OEL committee selects a critical effect in the 
key study identified through a literature review. The POD, 
which may be either the NOAEL/LOAEL or preferably 
the BMD, is derived based on the available data. Similarly 
to the current practices, the relevant assessment factors 
were considered one after the other. But rather than se-
lecting a single AF value, the experts will consider a range 
of possible values, defined by their 5th and 95th percen-
tiles. The choice of the appropriate AFs and their range is 
discussed by the experts from the OEL committee. Start-
ing from a broad initial (default) distribution, the experts 
have to narrow it to its most likely range according to the 
current scientific knowledge about the studied substance.
The distributions obtained for individual assessment 
factors are combined to get the resulting distribution of 
the AF (AFR) and subsequently, the most likely distribu-
tion of the human equivalent dose (HED). The default 
distributions considered by the French OEL Commit-
tee [3] are presented in the Table 1. These distributions 
are derived from the assessment factor’s ranges currently 
used by the Committee, assuming that the upper and low-
er values represent the most likely range of the AF. For 
all AFs, the upper value is set as the 95th percentile. The 
lower value is set as the 5th percentile or minimum, de-
pending on the context.
According to the short literature analysis conducted, 
a lognormal or shifted lognormal distribution is assumed 
for all AFs except for the AFD. A shifted lognormal dis-
tribution is chosen for the AFL, to take into account that 
the LOAEL is not expected to be lower than its associ-
ated NOAEL, assuming the monotonicity in the dose-
Define an occupational
exposure limits (OEL)
Assessment factor i (AF )i
Default distribution
of AFi
Expert
judgment
” ”Narrowed distribution
of AFi
Resulting AF (AF ) distributionR
AF = ∏ AFR i
Resulting OEL distribution
HED = POD/AFR
Recommended
OEL value
Expert
judgment
Choose percentile xth
Next
relevant AF
HED – human equivalent dose; POD – point of departure.
Fig. 2. Overview of the framework proposed to establish 
an occupational exposure limit (OEL) value  
based on the probabilistic approach
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ity (AFH) and differences in exposure duration extrapola-
tion (AFS). The AFA of 3 was considered to be sufficiently 
prudent for the extrapolation of hematotoxic effects. 
The AFH was set to 10, which was above the usual default 
value in the occupational population, but was deemed 
necessary because of the high inter-individual variability 
of enzymatic metabolism (e.g., according to ethnic origin). 
The value of the AFS was set to 3, to take into account 
the subchronic to chronic extrapolation. These choices 
led to the following deterministic OELs: 3.75 mg/m3 for 
the EGEE and 5.5 mg/m3 for the EGEEA.
Following the same reasoning through a probabilis-
tic approach would have led to 3 lognormal distribu-
tions for the AFA, AFH and AFS, with percentiles ranges 
of 1(P0.05)–3(P0.95), 1(P0.05)–10(P0.95), and 1(P0.05)–3(P0.95), 
respectively. The resulting distributions of the equiva-
lent HED for the EGEE and EGEEA are shown in 
the Figure 3 and Table 2. The values range 0.1 mg/m3– 
1851 mg/m3 and 0.1–2716 mg/m3, respectively. For the 
EGEE, the deterministic OELs of 3.75 mg/m3 were pro-
posed by the OELs committee. We can observe that this 
value corresponds to the 9th percentile of the EGEE HED 
distribution. The most likely value of 5.5 mg/m3 (the 
mode) of the distribution, was about 1.5 times higher 
than the chosen OEL. For the EGEEA, the determinis-
dynamic differences and includes the allometric adjust-
ment. When the allometric and/or dosimetric adjustments 
are already considered, for instance, when using data is-
sued from physiologically based pharmacokinetic (PBPK) 
modeling, the 95th percentile of the distribution could be 
reduced accordingly.
Similarly to the scheme currently in use in most OELs’ 
Committees, its probabilistic nature allows for conveying 
information about uncertainties up to the final recommen-
dation. Moreover, it allows for a clear distinction between 
adjustments intended to cope with uncertainties and safe-
ty margins (the choice of a given percentile of the final 
distribution).
Application to some case studies
To establish the French OELs for the EGEE and EGEEA, 
the ANSES OELs committee started with the POD 
of 375 mg/m3 and 550 mg/m3, respectively. These values 
corresponded to the NOAELs for hematotoxic effects, 
from experimental study on rats and rabbits published by 
Barbee et al. [23]. The rats were repeatedly exposed by 
the inhalation route 6 h/day, 5 days/week during 13 weeks. 
Following its usual regular deterministic approach [1], the 
committee considered 3 assessment factors: inter-species 
differences extrapolation (AFA), inter-individual variabil-
Table 1. Default distributions considered by the French OEL Committee when setting assessment factors (AF)  
without prior information [3]
Assessment factor
Probability distribution
shape parameters
For inter-species differences (AFA) (pharmacokinetics, pharmacodynamics) lognormal P0.05 = 1; P0.95 = 10
For inter-individual variability (AFH) lognormal P0.05 = 1; P0.95 = 5
For LOAEL to NOAEL (AFL) lognormal-like* min. = 1; P0.95 = 10
For differences in exposure duration (AFS) lognormal P0.05 = 1; P0.95 = 10
For quality of data (AFD) uniform min. = 1; max = 10
LOAEL – lowest-observed-adverse-effect level; NOAEL – no-observed-adverse-effect level.
P – percentiles; min. – minimal value; max – maximal value; Y – transformed distribution (shifted on the right); X – initial distribution.
* Y ≈ lognormal-like (min. = 1; P0.95 = 10) if Y = 1+X with X ≈ lognormal (P0.05 = 1; P0.95 = 9).
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distribution based on available data and expert judgment. 
All the distributions of the relevant AFs are combined, 
using statistical techniques, to quantify the uncertainty in 
the final result. Several shapes of the AF’s distribution are 
possible: lognormal, uniform, triangular. Available litera-
ture on the possible distribution of inter- and intra-species 
effects, ratios of LOAELs to NOAELs, and differences in 
acute and chronic effects suggest that most AFs tend to be 
approximately lognormally distributed. In the probabilis-
tic value of 5.5 mg/m3 was established by the committee. 
According to the probabilistic approach, the most likely 
value of the distribution was of 8.1 mg/m3, corresponding 
to the 9th percentile of the EGEEA HED distribution.
DISCUSSION
The probabilistic approach to establish OELs is pres-
ented in this paper. In this approach, each AF used is 
considered to be a random variable with a probabilistic 
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Fig. 3. Human equivalent dose for a) ethylene glycol monoethyl ether (EGEE), b) ethylene glycol monoethyl  
ether acetate (EGEEA)
Table 2. Statistics of the resulting human equivalent dose distributions for ethylene glycol monoethyl ether (EGEE) and  
ethylene glycol monoethyl ether acetate (EGEEA)
Substance
Concentration
[mg/m3]
min. P0.05 P0.5 M mode* P0.95 max SD
EGEE 0.1 2.7 16.8 30.9 5.5 103.3 1 851.5 48.6
EGEEA 0.1 4.0 24.6 45.3 8.1 151.3 2 715.5 71.3
P – percentiles; min. – minimal value; max – maximal value; M – mean; SD – standard deviation.
* The most likely value.
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 – It avoids the ruling out of some chemicals or some stud-
ies from the OELs process. According to the methodol-
ogy of the OEL Committee [1], a key study should not 
be used for the establishment of OELs if it is necessary 
to apply more than 3 assessment factors to the POD or 
if the total value of these factors exceeds 1000. A more 
adequate exclusion criteria could be used with a proba-
bilistic, considering the extent of the uncertainty distri-
bution for the resulting AFR [3].
 – The probabilistic approach is also more transparent: in-
stead of being a deterministic figure, the OEL would be 
derived based on the distribution of values that reflects 
the experts’ committee knowledge of each factor and its 
variability or uncertainty.
The point estimate proposed in the deterministic ap-
proach is the result of an expert consensus that is not al-
ways visible in the final outcome. The choice of a single 
value of the AF, sometimes arbitrary, does not reflect 
the richness of the panel discussion and real uncertainty 
around the decision. The AFs are often mixtures of mul-
tiple concepts. They may reflect variability, and/or uncer-
tainty adjustments. Depending on the context and avail-
able level of information, the AF value may be the most 
probable estimate, a prudent estimate or a median value 
between these 2 bounds.
Furthermore, it is not clear whether the choice of such 
a value reflects real variability or uncertainty related to the 
lack of adequate data. Disclosing the uncertainty and vari-
ability inherent to the OEL construction process should 
better support the decision making and, ultimately the ac-
ceptance of the final OEL value. The expert judgement 
and debate will still be encouraged but instead of being 
focused on the choice of assessment factors to be applied 
and the value assigned to each of these factors, it will fo-
cus on the shape of distributions and the extreme values, 
i.e., the lower and upper bounds of the distributions.
Currently, when deriving occupational exposure values, 
the fraction of the population which should be protected 
tic approach, each AF is replaced by a lognormal distribu-
tion based on empirical observations to identify, median, 
standard deviation, and percentiles. The default distribu-
tions are to be considered as a starting point, prior to the 
debate among experts. Default distributions are defined 
by the 5–95th percentile range or min.–max range, assum-
ing that 90% and 100% of the values should fall within this 
range, respectively. Assuming that the uncertainty factors 
are independent and lognormal-distributed, the logarithm 
of their product is being distributed as the sum of normally 
distributed variables; the percentiles of the resulting dis-
tribution are easily computed.
When chemical specific information is available, chemi-
cal-specific adjustment factors (CSAFs) could be used for 
replacing default AFs, according to the scheme adopted 
by the World Health Organization/International Program 
on Chemical Safety [24,25]. In most cases, detailed CSAFs 
are, however, not available and full probabilistic doses-
response assessments [26,27] are not possible. The prag-
matic approach considered by the French OEL commit-
tee adds a probabilistic dimension to the expert judgment 
process, disclosing the uncertainties of decision making of 
the OELs.
The use of the probabilistic approach has several ad- 
vantages:
 – By assigning a probabilistic distribution to each AF, it 
avoids having to systematically multiply “worst-case” 
situations. In the deterministic approach, very prudent 
assessment factors are often chosen and they are multi-
plied together. This results in a high overall factor that 
leads to a low limit value [28]. Thus, due to the mul-
tiplication of assessment factors, the choice of default 
values may rapidly lead to OELs that are unrelated to 
the relevant concentrations in terms of health. While 
this over-cautious approach does favor worker protec-
tion and promotes a “lowest” exposure objective, it 
has severe drawbacks in terms of risk prioritization for 
both authorities and companies.
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deterministic approach, but with the appropriate soft-
ware and standardized probabilistic inputs, the increase 
in time and effort is minimal in most cases.
 – Not all expert choices are considered in the proba-
bilistic approach (e.g., selection of mode of action 
(MoA)/critical effect, critical study, quality, data 
gap analysis), which only reflects the uncertainty 
and variability of the assessment factors. Because of 
this, the OEL construction process should continue 
to put emphasis on the qualitative decision made by 
the experts.
The probabilistic approach is well-suited for PODs with 
a benchmark dose. The BMD, being probabilistic by na-
ture, takes into account the whole range of tested doses 
to identify the effect instead of the deterministic choice 
of the NOAEL/LOAEL. The BMD and BMDL concepts 
are other appropriate tools to better describe the uncer-
tainty around the point of departure (POD). Although 
the use of BMD is more and more frequent, it had not 
been included in this project which has primarily been fo-
cused on substances without enough dose-response data 
to derive the BMD/BMDL. The combination of proba-
bilistic approaches for both POD and AFs is planned in 
the future.
How the probabilistic approach could be used by risk 
managers is still a matter of debate. The most likely distri-
bution of the HED value conveys important information 
about its associated uncertainties, according to the cur-
rent level of knowledge. Moreover, the sensitivity analysis 
could be encouraged so that the parameters that most in-
fluence the result are identified. As such, this information 
should be part of the support data available to the decision 
maker who will set the final regulatory value.
In France, the OELs advocated by Anses to the Ministry 
of Labour are discussed by stakeholders before being im-
plemented in the regulation. The final OELS could be 
an indicative value or binding ones. It would be perfect 
if mandatory values were attributed to substances with 
is rarely specified. The incidence, reflecting the likelihood 
of an event occurring, is often specified for genotoxic car-
cinogens (e.g., 10−5 for workers), but not for other types 
of effects. When the BMD approach is used, the typical 
coverage used is 90%, but this coverage relates only to the 
benchmark dose level (BMDL), not to the OEL value. 
Moreover, the degree of uncertainty and variability in the 
available scientific information should be explicitly con-
sidered. In the approaches described in our manuscript, 
the degree of uncertainty in estimating the OEL and its 
coverage (the probability that it provides the intended 
level of protection) is quantified. Therefore, we think that 
this approach may be useful for risk managers. It pro-
vides basis for the weighing of hazards and their uncer-
tainty against other factors relevant for risk management 
decision-making.
Furthermore, moving from the deterministic approach to 
a probabilistic one also appears adequate in the context 
of the derived-no-effect level (DNEL) elaborated under 
the REACH regulation [29]. More and more DNELs 
are being developed in order to cover the requirements 
of REACH for new substances. One can easily anticipate 
that the number of chemicals to be addressed to within 
the REACH regulatory framework is well beyond the ca-
pability of the OELs’ experts committees to produce ref-
erence values. The DNELS and OELs construction logic 
is often opposed as if unrelated. Providing a distribution 
rather than a single deterministic value would highlight 
the continuum existing between the 2 values. In principle, 
both OELs and DNEL should be issued from the same 
uncertainly distribution. While uncertainties are expected 
to be much higher in DNELS (i.e., less data available), 
a more conservative percentile of the distribution should 
be chosen, leading to a lower end value.
Some limits in using the probabilistic approach also have 
to be pointed out:
 – The calculations described in the probabilistic ap-
proach are by nature more complex than those in the 
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